Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.
Haberberger JF, Pegram W, Britt N, Schiavone K, Severson E, Sharaf R, Albacker LA, Williams E, Lechpammer M, Hemmerich A, Lin D, Huang RSP, Hiemenz M, Elvin J, Graf R, Lesser G, Kram D, Strowd R, Bi WL, Ramkissoon LA, Cohen MB, Reddy P, Creeden J, Ross JS, Alexander BM, Ramkissoon SH. Haberberger JF, et al. Oncologist. 2024 Jan 5;29(1):e47-e58. doi: 10.1093/oncolo/oyad224. Oncologist. 2024. PMID: 37619245 Free PMC article.
A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.
Johnson SM, Haberberger J, Galeotti J, Ramkissoon L, Coombs CC, Richardson DR, Foster MC, Duncan D, Zeidner JF, Ferguson NL, Montgomery ND. Johnson SM, et al. Among authors: haberberger j. Blood Cancer J. 2023 Jun 26;13(1):96. doi: 10.1038/s41408-023-00876-w. Blood Cancer J. 2023. PMID: 37365170 Free PMC article. No abstract available.
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer.
Hill BL, Graf RP, Shah K, Danziger N, Lin DI, Quintanilha J, Li G, Haberberger J, Ross JS, Santin AD, Slomovitz B, Elvin JA, Eskander RN. Hill BL, et al. Among authors: haberberger j. Int J Gynecol Cancer. 2023 Apr 3;33(4):504-513. doi: 10.1136/ijgc-2022-004026. Int J Gynecol Cancer. 2023. PMID: 36750267 Free PMC article. Clinical Trial.
Genomic Profiling Reveals Differences in Primary Central Nervous System Lymphoma and Large B-Cell Lymphoma, With Subtyping Suggesting Sensitivity to BTK Inhibition.
Severson EA, Haberberger J, Hemmerich A, Huang RSP, Edgerly C, Schiavone K, Najafian A, Hiemenz M, Lechpammer M, Vergilio JA, Lesser G, Strowd R, Elvin J, Ross JS, Hegde P, Alexander B, Singer S, Ramkissoon S. Severson EA, et al. Among authors: haberberger j. Oncologist. 2023 Jan 18;28(1):e26-e35. doi: 10.1093/oncolo/oyac190. Oncologist. 2023. PMID: 36342081 Free PMC article.
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy by Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer.
Graf RP, Fisher V, Weberpals J, Gjoerup O, Tierno MB, Huang RSP, Sayegh N, Lin DI, Raskina K, Schrock AB, Severson E, Haberberger JF, Ross JS, Creeden J, Levy MA, Alexander BM, Oxnard GR, Agarwal N. Graf RP, et al. Among authors: haberberger jf. JAMA Netw Open. 2022 Mar 1;5(3):e225394. doi: 10.1001/jamanetworkopen.2022.5394. JAMA Netw Open. 2022. PMID: 35357449 Free PMC article.
Correlating ROS1 Protein Expression With ROS1 Fusions, Amplifications, and Mutations.
Huang RSP, Gottberg-Williams A, Vang P, Yang S, Britt N, Kaur J, Haberberger J, Danziger N, Owens C, Beckloff SE, Ross JS, Ramkissoon SH. Huang RSP, et al. Among authors: haberberger j. JTO Clin Res Rep. 2020 Sep 18;2(2):100100. doi: 10.1016/j.jtocrr.2020.100100. eCollection 2021 Feb. JTO Clin Res Rep. 2020. PMID: 34589979 Free PMC article.
Landscape of Biomarkers in Non-small Cell Lung Cancer Using Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry.
Huang RSP, Severson E, Haberberger J, Duncan DL, Hemmerich A, Edgerly C, Ferguson NL, Frampton G, Owens C, Williams E, Elvin J, Vergilio JA, Killian JK, Lin D, Morley S, McEwan D, Holmes O, Danziger N, Cohen MB, Sathyan P, McGregor K, Reddy P, Venstrom J, Anhorn R, Alexander B, Brown C, Ross JS, Ramkissoon SH. Huang RSP, et al. Among authors: haberberger j. Pathol Oncol Res. 2021 Mar 11;27:592997. doi: 10.3389/pore.2021.592997. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34257540 Free PMC article.
Erratum to: FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
Sharaf R, Pavlick DC, Frampton GM, Cooper M, Jenkins J, Danziger N, Haberberger J, Alexander BM, Cloughesy T, Yong WH, Liau LM, Nghiemphu PL, Ji M, Lai A, Ramkissoon SH, Albacker LA. Sharaf R, et al. Among authors: haberberger j. Neurooncol Adv. 2021 Jun 22;3(1):vdab059. doi: 10.1093/noajnl/vdab059. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34169283 Free PMC article.
21 results